Status:
COMPLETED
Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia
Lead Sponsor:
Henry Ford Health System
Conditions:
ESRD
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bact...
Detailed Description
Scope of the problem. A large number of hemodialysis patients in this country rely on indwelling tunneled and non-tunneled catheters as vascular access for hemodialysis even though the K/DOQI guidelin...
Eligibility Criteria
Inclusion
- ESRD patients with tunnelled catheters
Exclusion
- patients on IV abx for infections, patients who have AV graft, AV fistulas
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00294502
Start Date
September 1 2003
End Date
May 1 2004
Last Update
February 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202